Alexander Karachunskiy
Overview
Explore the profile of Alexander Karachunskiy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Semchenkova A, Mikhailova E, Demina I, Roumiantseva J, Karachunskiy A, Novichkova G, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076625
Multicolor flow cytometry (MFC) is a key method for assessing measurable residual disease (MRD) in acute lymphoblastic leukemia (ALL). However, very few approaches were developed for MRD in T-cell ALL...
2.
Itov A, Ilyasova K, Soldatkina O, Kazakova A, Kozeev V, Semchenkova A, et al.
EJHaem
. 2024 Oct;
5(5):1010-1013.
PMID: 39415918
Pediatric low-hypodiploidy B-cell acute lymphoblastic leukemia (LH-ALL) with variants has been proposed to be considered a manifestation of Li-Fraumeni syndrome (LFS). However, our study demonstrates that of the majority the...
3.
Sinichenkova K, Sidorov I, Kriventsova N, Konovalov D, Abasov R, Usman N, et al.
Oncotarget
. 2024 Jul;
15:493-500.
PMID: 39018206
Introduction: BRAF V600E substitution predicts sensitivity of a cancer to BRAF inhibitor therapy. The mutation is rarely found in soft-tissue sarcomas. Here we describe a case of undifferentiated spindle cell...
4.
Papusha L, Zaytseva M, Panferova A, Salnikova E, Samarin A, Vilesova I, et al.
JCO Precis Oncol
. 2024 Jul;
8:e2300590.
PMID: 38976815
Purpose: Midline low-grade gliomas (mLGGs) of early childhood have a poorer prognosis compared with tumors of other localizations and in older patients. LGGs are associated with aberrant activation of RAS-RAF-MEK...
5.
Demina I, Dagestani A, Borkovskaia A, Semchenkova A, Soldatkina O, Kashpor S, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38891797
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) develops from very early cells with the potential for both T-cell and myeloid differentiation. The ambiguous nature of leukemic blasts in ETP-ALL may...
6.
Papusha L, Zaytseva M, Senchenko M, Sanakoeva A, Panferova A, Sharanda T, et al.
Pediatr Blood Cancer
. 2024 Jun;
71(9):e31149.
PMID: 38884269
No abstract available.
7.
Mikhailova E, Popov A, Roumiantseva J, Budanov O, Lagoyko S, Zharikova L, et al.
J Immunother Cancer
. 2024 Jun;
12(6).
PMID: 38844406
The bispecific T cell-binding antibody blinatumomab (CD19/CD3) is widely and successfully used for the treatment of children with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here, we report...
8.
Popov A, Henze G, Tsaur G, Budanov O, Roumiantseva J, Belevtsev M, et al.
Cancer Med
. 2024 Apr;
13(8):e7172.
PMID: 38651186
Background: Quantitative measurement of minimal residual disease (MRD) is the "gold standard" for estimating the response to therapy in childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Nevertheless, the speed of...
9.
Demina I, Mikhailova E, Zerkalenkova E, Semchenkova A, Roumiantseva J, Borkovskaya A, et al.
Am J Clin Pathol
. 2024 Mar;
162(2):180-190.
PMID: 38513276
Objectives: Mixed-phenotype acute leukemia (MPAL) is a rare disease associated with difficulties in the correct lineage assignment of leukemic cells. One of the least common subtypes within this category is...
10.
Popov A, Henze G, Roumiantseva J, Bydanov O, Belevtsev M, Verzhbitskaya T, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067249
Methods: Conventional induction therapy consisted of dexamethasone, vincristine, and daunorubicin. MRD data was available in 502 patients who were randomized at the start of induction therapy, standard-risk (SR) patients into...